Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

 

Gainers

  • Healthcare Triangle (NASDAQ:HCTI) stock moved upwards by 17.5% to $1.35 during Wednesday's pre-market session. The company's market cap stands at $47.6 million.
  • TransCode Therapeutics (NASDAQ:RNAZ) stock rose 17.24% to $3.4. The company's market cap stands at $43.8 million. The company's, Q4 earnings came out 4 days ago.
  • BioXcel Therapeutics (NASDAQ:BTAI) shares increased by 16.19% to $23.1. The company's market cap stands at $646.3 million.
  • Tilray (NASDAQ:TLRY) stock rose 11.09% to $7.81. The market value of their outstanding shares is at $3.7 billion. As per the news, the Q3 earnings report came out today.
  • Citius Pharmaceuticals (NASDAQ:CTXR) stock increased by 10.86% to $2.04. The company's market cap stands at $297.9 million.
  • TC BioPharm (Holdings) (NASDAQ:TCBP) stock moved upwards by 9.67% to $1.7. The market value of their outstanding shares is at $47.6 million.

Losers

  • Celsion (NASDAQ:CLSN) stock decreased by 17.7% to $5.12 during Wednesday's pre-market session. The market value of their outstanding shares is at $29.5 million. As per the news, the Q4 earnings report came out 4 days ago.
  • Reneo Pharmaceuticals (NASDAQ:RPHM) shares declined by 14.94% to $2.45. The company's market cap stands at $59.9 million.
  • GlucoTrack (NASDAQ:GCTK) shares declined by 11.91% to $2.59. The market value of their outstanding shares is at $40.0 million.
  • Nutex Health (NASDAQ:NUTX) shares declined by 10.67% to $23.8.
  • Evoke Pharma (NASDAQ:EVOK) stock fell 10.46% to $0.37. The company's market cap stands at $12.1 million.
  • Biophytis (NASDAQ:BPTS) shares decreased by 10.36% to $2.25. The market value of their outstanding shares is at $29.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.